Clinical Trial Update: Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing Fluticasone Propionate Nasal Spray 50 mcg/Actuation to Flonase in seasonal allergic rhinitis was terminated; results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Flonase (fluticasone propionate nasal spray)
• Fluticasone propionate nasal spray 50 mcg/actuation (fluticasone propionate nasal spray)

Snippet

Sponsor: Teva Pharmaceuticals USA | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: TERMINATED | Results posted: 2023-06-08